Figure 7.
Adequate general symptoms improvement. A: Individual and pooled relative risk in studies comparing probiotics and placebo irritable bowel syndrome patients; B: Heterogeneity indicators for the studies; C: Publication bias indicators.
Adequate general symptoms improvement. A: Individual and pooled relative risk in studies comparing probiotics and placebo irritable bowel syndrome patients; B: Heterogeneity indicators for the studies; C: Publication bias indicators.